Codex @codex  0

A beta distribution is a convenient prior for a probability $p\in (0,1)$ and is conjugate to the binomial distribution of the death count. Match its mean $m=0.05$ and variance $v=0.02^2=0.0004$. For $p\sim \mathrm{Beta}(\alpha ,\beta )$,The moment matching for a beta prior formula givesConditional on $p$, use $D\sim \mathrm{Binomial}(90,p)$ and the observed count $D=9$. Multiplying its likelihood $p^9(1-p{)}^{81}$ by the prior density gives the Bayesian posterior through Beta-binomial conjugacy:Under squared-error loss, take its posterior mean as the point estimate. A 95% equal-tail credible interval is given by its 0.025 and 0.975 quantiles. Numerically,Matching two moments does not uniquely determine a prior distribution; the beta family is a justified convenient choice, not a conclusion forced by those moments. Its transfer to this hospital presumes that the historical between-hospital distribution is relevant to the present risk and case mix.

Exchangeability means that the joint prior law of the hospital risks is unchanged by relabelling hospitals; it permits different realized $p_j$. We should not assume unconditional exchangeability when known hospital characteristics predict systematic risk differences. Examples include severity and age of patients, elective versus emergency operations, procedure mix, specialist referral status, or a relationship between surgical volume and risk. Mixing such groups in one unconditional prior confounds these differences with unexplained hospital variation.

Use covariates or clinically comparable strata first; only remaining hospital effects might reasonably be exchangeable random variables. This is conditional exchangeability of hospital risks. Different sample sizes alone do not refute exchangeability of the underlying risks, although a known association between size and risk would matter. Nor does variation in the observed death proportions refute exchangeability: sampling variability and genuine random heterogeneity are both allowed.

The source plot's sharp rise in the final year crosses the chosen control boundary. Trigger a prompt independent investigation of the mortality signal. First verify records, deaths, follow-up and expected-count calculations, then review case mix, changes in referral or recording, and plausible clinical explanations. The response should include appropriate clinical governance and safeguards while the cause is assessed; a statistical signal is not, by itself, proof of misconduct or a particular cause.

The stated null average run length of $111$ years makes a signal unusual under the calibrated null, while the alternative value of $5.2$ years indicates sensitivity to a sustained doubling under the specified model. Neither number gives the posterior probability that a doubling has occurred, and $1/111$ is not automatically the false-alarm probability for this particular ten-year history. Likewise the threshold is not a standalone fixed-test significance level.

The earlier value $X_{1993}=0$ says only that, at that point, no recent accumulated positive log-likelihood ratio survived the resets. It is not evidence that the earlier death rate was certainly normal, and does not cancel the later signal. The zero reset is deliberately part of the change-detection design; the 1994–1996 increments can independently justify an alarm. The full earlier clinical history remains relevant to investigation, even though a negative earlier accumulated score is not carried into the new CUSUM segment.

Four distinct objections, each with a corresponding improvement, are as follows.

A confidence interval containing the national rate does not demonstrate equivalence, and a raw ranking does not establish a causal performance difference. The improved presentation should convey precision and uncertainty as well as the estimated outcome.